Holen Sie sich die Stockscreener-App
32.25
0.46%
-0.15
Handel nachbörslich:
32.25
Schlusskurs vom Vortag:
$32.40
Offen:
$31.48
24-Stunden-Volumen:
702.90K
Relative Volume:
0.78
Marktkapitalisierung:
$2.56B
Einnahmen:
$517.15M
Nettoeinkommen (Verlust:
$66.35M
KGV:
39.27
EPS:
0.8212
Netto-Cashflow:
$126.63M
1W Leistung:
-1.68%
1M Leistung:
-10.44%
6M Leistung:
-9.49%
1J Leistung:
+7.04%
1-Tages-Spanne:
$31.48
$33.18
1-Wochen-Bereich:
$29.45
$33.54
52-Wochen-Spanne:
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
Firmenname
Veracyte Inc
Sektor
Branche
Telefon
(650) 243-6300
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
32.25 | 2.56B | 517.15M | 66.35M | 126.63M | 0.8212 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.55 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.48 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.24 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Underweight |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Hold |
| 2025-03-20 | Eingeleitet | Craig Hallum | Buy |
| 2024-12-05 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-16 | Eingeleitet | UBS | Buy |
| 2024-10-10 | Eingeleitet | Guggenheim | Buy |
| 2024-02-23 | Bestätigt | Needham | Buy |
| 2023-01-18 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-11-18 | Fortgesetzt | Goldman | Buy |
| 2021-06-15 | Eingeleitet | Raymond James | Outperform |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2019-07-31 | Eingeleitet | Lake Street | Buy |
| 2019-07-02 | Eingeleitet | Needham | Buy |
| 2018-11-29 | Herabstufung | Janney | Buy → Neutral |
| 2018-10-31 | Hochstufung | Janney | Neutral → Buy |
| 2017-11-07 | Herabstufung | Janney | Buy → Neutral |
| 2017-11-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Fortgesetzt | BTIG Research | Buy |
| 2016-11-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-18 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-11 | Bestätigt | Leerink Partners | Outperform |
| 2013-11-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
VCYT Technical Analysis & Stock Price Forecast - intellectia.ai
VCYT PE Ratio & Valuation, Is VCYT Overvalued - intellectia.ai
Veracyte (VCYT) down 15.4% since last earnings report: Can it rebound? - MSN
Veracyte Inc (NASDAQ:VCYT) Emerges as a Prime Growth at a Reasonable Price (GARP) Candidate - ChartMill
Precision Trading with Veracyte Inc. (VCYT) Risk Zones - Stock Traders Daily
Veracyte (VCYT): Needham Reaffirms "Buy" Rating with $48 Price T - GuruFocus
Veracyte (NASDAQ:VCYT) Given "Buy" Rating at Needham & Company LLC - MarketBeat
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $48 - Moomoo
Needham reiterates Veracyte stock rating on bladder cancer test plans - Investing.com
Veracyte, Inc. (VCYT) stock price, news, quote and history - uk.finance.yahoo.com
Cathie Wood’s ARK buys OpenAI Group stock, sells Veracyte shares By Investing.com - Investing.com India
Cathie Wood’s ARK buys OpenAI Group stock, sells Veracyte shares - Investing.com
Is Veracyte Stock a Smart Addition to Your Investment Portfolio at This Time? - Bitget
Is Veracyte Stock the Right Pick for Your Portfolio Now? - Yahoo Finance Singapore
MACD Signal: Is Veracyte Inc stock a value trap2026 Top Decliners & Real-Time Price Movement Reports - baoquankhu1.vn
VCYT SEC FilingsVeracyte 10-K, 10-Q, 8-K Forms - Stock Titan
Veracyte price target lowered to $45 from $50 at Guggenheim - TipRanks
Exit Recap: Is Veracyte Inc a strong candidate for buy and hold2026 Analyst Calls & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Guggenheim Maintains Buy Rating, Lowers Price Target on VCYT to $45 | VCYT Stock News - GuruFocus
Veracyte (NASDAQ:VCYT) Price Target Lowered to $45.00 at Guggenheim - MarketBeat
Guggenheim Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $45 - Moomoo
Does Veracyte (NASDAQ:VCYT) Deserve A Spot On Your Watchlist? - Moomoo
Veracyte (NASDAQ:VCYT) Shares Down 9.2%What's Next? - MarketBeat
Vanguard disaggregates reporting; lists zero holdings in Veracyte (VCYT) - stocktitan.net
Veracyte (VCYT) Down 15.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Volatility Watch: Is Veracyte Inc stock a top performer YTDPortfolio Return Report & Expert Approved Trade Ideas - baoquankhu1.vn
Veracyte, Inc. $VCYT Shares Sold by Nordea Investment Management AB - MarketBeat
Veracyte, Inc. $VCYT Shares Acquired by JPMorgan Chase & Co. - MarketBeat
Update Report: Should value investors consider Veracyte Inc2026 Trade Ideas & Weekly High Return Forecasts - baoquankhu1.vn
Veracyte (VCYT) Chief Dev and Tech Officer files initial Form 3 - Stock Titan
Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Veracyte Taps Kevin Haas To Guide AI Push And Undervalued Shares - Sahm
TGI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Westview Management dba Westview Investment Advisors Invests $1.38 Million in Veracyte, Inc. $VCYT - MarketBeat
Does Veracyte (VCYT) offer both strength and opportunity? - MSN
Veracyte Names Kevin Haas as Chief Development and Technology Officer - StreetInsider
Breakouts Watch: Can Veracyte Inc expand into new marketsQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
How Veracyte’s New AI-Focused CTO Role At Veracyte (VCYT) Has Changed Its Investment Story - simplywall.st
Veracyte appoints Kevin Haas as chief development officer By Investing.com - Investing.com Australia
Veracyte CFO Chambers sells $662k in VCYT stock - Investing.com Nigeria
Veracyte (VCYT) Appoints New Chief Development and Technology Of - GuruFocus
Veracyte names Kevin Haas as Chief Development and Technology Officer - TipRanks
Veracyte names Kevin Haas as chief development and technology officer - marketscreener.com
Veracyte Names Kevin Haas As Chief Development And Technology Officer - TradingView
Veracyte Appoints Kevin Haas as Chief Technology Leader - TipRanks
Veracyte Appoints Kevin Haas as Chief Development and Technology Officer - marketscreener.com
Veracyte appoints Kevin Haas as chief development officer - Investing.com
Veracyte (NASDAQ: VCYT) hires Kevin Haas as Chief Development and Technology Officer - Stock Titan
Veracyte, Inc. Appoints Kevin Haas as Chief Development and Technology Officer, Effective March 24, 2026 - marketscreener.com
Iron Triangle Partners LP Purchases New Position in Veracyte, Inc. $VCYT - MarketBeat
Finanzdaten der Veracyte Inc-Aktie (VCYT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Veracyte Inc-Aktie (VCYT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Stapley Marc | Chief Executive Officer |
Mar 04 '26 |
Sale |
35.97 |
45,523 |
1,637,594 |
357,554 |
| Leite John | Chief Commercial Officer-CLIA |
Mar 04 '26 |
Sale |
35.19 |
5,260 |
185,083 |
107,580 |
| McGuire Annie | SVP, General Counsel |
Mar 04 '26 |
Sale |
35.55 |
6,658 |
236,725 |
94,706 |
0.17%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):